Kendall Law Group Investigates Forest Laboratories, Inc. for Shareholders

Kendall Law Group, led by former federal judge Joe Kendall, is investigating Forest Laboratories, Inc. (NYSE: FRX) for shareholders. The national securities firm’s investigation seeks to determine whether Forest Laboratories and its Board have breached their fiduciary duties. If you are a Forest Laboratories shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at skendall@kendalllawgroup.com.

On February 22, 2011, Forest Laboratories announced a definitive merger agreement under which Clinical Data Inc would be acquired by Forest Laboratories, in a transaction valued at approximately $1.2 billion. Announcement of the merger triggered the firm’s investigation into potential breaches of fiduciary duties by the board of Forest Laboratories.

Kendall Law Group has the credentials and experience to pursue any type of complex securities litigation in the nation. The firm represents shareholders nationwide when publicly traded companies violate the law. Shareholders are urged to contact attorney Scott Kendall for more information.

Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Oct 2024 to Nov 2024